Top ALK ex­pert and can­cer drug re­searcher Al­ice Shaw bids adieu to acad­e­mia, hel­lo to No­var­tis

Jay Brad­ner has re­cruit­ed a mar­quee on­col­o­gy drug re­searcher in­to the ranks of the No­var­tis In­sti­tutes for Bio­Med­ical Re­search. Al­ice Shaw is jump­ing from pres­ti­gious posts in­ter­twined through Mass Gen­er­al, Har­vard and Dana-Far­ber to take the lead of NI­BR’s trans­la­tion­al clin­i­cal on­col­o­gy group.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER